Issues in Oocyte Donation for Stem Cell Research
Authors:
- 17 June 2005
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 308 (5729) , 1747-1748
Abstract
Stem cell research on human embryonic stem cells derived through use of oocytes originally obtained specifically for research and not for reproductive or medical purposes creates a new class of research subject. In this Policy Forum, the authors explore the ethical issues for those who perform such studies and for research donors. Healthy oocyte donors differ from traditional research subjects in that neither they nor their tissues are the direct objects of study but their tissues are used to create materials for research. Yet they are exposed to significant risks and have no prospect of direct benefit. Researchers in the U.S. who conduct such studies in other countries should follow U.S. guidelines such as those recently released by the National Research Council-Institute of Medicine, even if they are not required by law, because of the special ethical considerations raised by this new category of research subject. The informed consent process for donors should not minimize the risks of oocyte procurement just because the donors are not giving their oocytes for reproductive purposes, or portray stem cell transplantation research as an existing therapy.Keywords
This publication has 18 references indexed in Scilit:
- Patient-Specific Embryonic Stem Cells Derived from Human SCNT BlastocystsScience, 2005
- Informed consent in human oocyte, embryo, and embryonic stem cell researchFertility and Sterility, 2004
- Uncertain benefit: investigators' views and communications in early phase gene transfer trialsMolecular Therapy, 2004
- Integrating ethics and science in the International HapMap ProjectNature Reviews Genetics, 2004
- Is this live-organ donor your patient?Transplantation, 2003
- Consent from Donors for Embryo and Stem Cell ResearchScience, 2003
- The nondirected live-kidney donor: ethical considerations and practice guidelinesTransplantation, 2002
- Consensus Statement on the Live Organ DonorJAMA, 2000
- Rewriting the "Points to Consider": The Ethical Impact of Guidance Document LanguageHuman Gene Therapy, 1999
- Ovarian Hyperstimulation SyndromeObstetrical & Gynecological Survey, 1989